A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2017; you can also visit the original URL.
The file type is
Coralan Experience (CORE) Survey – First Malaysian Experience of Ivabradine in Stable Angina
Pharmaceutica Analytica Acta
In addition to baseline demographic data, concomitant comorbidities were noted. Background pharmacological treatment classes -antiplatelets, anti-ischaemic therapies, lipid lowering agents, ACE-inhibitors, etc. (without dosages) were recorded. Abstract Aims: This non-randomised observational study primarily sought to evaluate the initial experiences with Ivabradine in these patients in terms of its efficacy in angina-related endpoints as well as highlighting safety issues, if any. This studydoi:10.4172/2153-2435.1000213 fatcat:3in4mfwj7vathdupveehvl4ugu